
Prokidney Corp.
PROKNasdaqCIK 1850270HealthcareFiscal year ends Dec 31
Reports and events: 117 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-07-0608:40 ET | 8-K | 8.01 Other events | 0001193125-22-188289 |
| 2022-06-1016:12 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-171949 |
| 2022-05-1617:13 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001193125-22-151998 |
| 2022-04-2807:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-125456 |
| 2022-04-2216:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-22-115149 |
| 2022-03-2417:32 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001193125-22-082906 |
| 2022-01-2116:33 ET | 8-K/A | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-22-014862 |
| 2022-01-1807:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-010520 |
| 2021-11-1616:31 ET | 8-K | 4.02 Non-reliance on financial statements | 0001193125-21-331273 |
| 2021-11-1517:11 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001193125-21-330114 |
| 2021-09-2416:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-282373 |
| 2021-08-1616:40 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001193125-21-247846 |
| 2021-07-0906:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-211210 |
| 2021-07-0216:22 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-207646 |
| 2021-06-2517:27 ET | S-1/A | Registration statement, amended | 0001193125-21-200628 |
| 2021-06-0906:15 ET | S-1/A | Registration statement, amended | 0001193125-21-185878 |
| 2021-06-0217:17 ET | S-1 | Registration statement | 0001193125-21-180036 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:06 ET. Listed shows no prices and gives no investment advice.